Ionis Pharmaceuticals, Inc. Deferred Tax Liabilities, Property, Plant and Equipment
Ionis Pharmaceuticals, Inc. (IONS) had Deferred Tax Liabilities, Property, Plant and Equipment of $8.06 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2026-02-26
- 2025-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $8.06M.
- 2024-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $5.72M.
- 2023-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $4.17M.
- 2022-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $4.47M.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment |
|---|---|
| 2025-12-31 | $8.06M 10-K · filed 2026-02-26 |
| 2024-12-31 | $5.72M 10-K · filed 2026-02-26 |
| 2023-12-31 | $4.17M 10-K · filed 2025-02-19 |
| 2022-12-31 | $4.47M 10-K · filed 2024-02-21 |
| 2021-12-31 | $3.30M 10-K · filed 2023-02-22 |
| 2020-12-31 | $3.61M 10-K · filed 2022-02-25 |
| 2019-12-31 | $1.96M 10-K · filed 2021-02-24 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |